During the past decade, Clinica IMA conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinica IMA" #1 collaborator was "Eucatech AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Clinica IMA" are "Coronary Artery Disease" (1 trials), "Coronary Heart Disease" (1 trials) and "Coronary Restenosis" (1 trials). Many other conditions were trialed in "Clinica IMA" in a lesser frequency.

Most popular intervention types in "Clinica IMA" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bare Metal Stent" (1 trials), "Drug Eluting Stent" (1 trials), "Drug Eluting stent" (1 trials) and "Oral sirolimus" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinica IMA" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Clinica IMA". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinica IMA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinica IMA, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".